| 摘要 |
<p>The present invention relates to the treatment of mammalian male infertility through the administration of fertility enhancing amounts of a fertility enhancing thymosin polypeptide or a fertility enhancing anti-thymosin antibody. In preferred embodiments, treaatment comprises the administration of thymosin α1 or antibodies to thymosin α1 or thymosin β4.</p> |
